Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. bought 9,704 shares of the firm’s stock in a transaction dated Monday, June 10th. The stock was bought at an average cost of $13.71 per share, with a total value of $133,041.84. Following the transaction, the insider now directly owns […]
Abrdn Life Sciences Investors (NYSE:HQL) Major Shareholder Saba Capital Management, L.P. Acquires 20,529 Shares theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) major shareholder Saba Capital Management, L.P. bought 81,738 shares of Abrdn Life Sciences Investors stock in a transaction dated Thursday, April 18th. The shares were acquired at an average price of $12.80 per share, with a total value of $1,046,246.40. Following the completion of the purchase, […]